article thumbnail

Reinventing the small molecule toolbox: from proteins to RNA

Dark Matter Blog

The bulk of my nearly three decades of experience up to that point was with drugging protein targets using a variety of modalities, but principally small molecules. The post Reinventing the small molecule toolbox: from proteins to RNA appeared first on Arrakis Therapeutics. Welcome to the RNA world.

article thumbnail

Only non-US company joins cancer drug discovery consortium

Drug Discovery World

Members contribute their expertise in high throughput screening, structural biology, medicinal chemistry, compound profiling, cancer cell biology, and in vivo and in vitro models for oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Condensate biology: advancing drug discovery for complex diseases

Drug Target Review

The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.

Disease 98
article thumbnail

Scientists uncover a new approach for treating aggressive cancer

The Pharma Data

They then developed a new therapeutic approach with a potent small-molecule inhibitor of this enzyme. Certain subtypes of blood cancers such as acute leukemias rely on multiple mechanisms for sustaining growth of aggressive cancer cells. Their findings are published online in Nature Cell Biology.

article thumbnail

Sitting down with… Neil Dhawan

Drug Discovery World

DDW Volume 24 – Issue 3, Summer 2023 Biography: Neil Dhawan is the Co-founder and CEO of Totus Medicines, where he focuses on combining small molecule design, structural biology, genetics, biochemistry, and cell biology to design new classes of drugs to target untreatable diseases.

article thumbnail

Role of second messengers in the cell | BMG LABTECH

BMG Labtech

Effectors of signal transmission events Second messengers are small molecules or ions that transmit signals received at the cell surface to the inside environment of the cell (Fig.

article thumbnail

Cancer metastasis: breakthrough in therapeutic strategies

Drug Target Review

When bound to GRP78, ID2 loses its inhibitory function, leading to increased invasiveness of cancer cells. Implications for cancer therapeutics and beyond These findings have wide-ranging implications for cancer treatment and cell biology research.